StemCell Therapy

Dublin, June 25, 2020 (GLOBE NEWSWIRE) -- The "Global CRISPR Market 2019-2028" report has been added to ResearchAndMarkets.com's offering.

The global CRISPR market is estimated to expand at a CAGR of 23.95% over the forecasting period 2019-2028.

The increasing lifestyle-oriented diseases, the rising prevalence of genetic diseases and the growing application of drugs are the primary factors driving the growth of the CRISPR market. In addition, the increasing geriatric population and the rising incidence of genetic ailments are also likely to lead to an increase in demand for global CRISPR technology. However, ethical issues associated with the technology and the changing regulatory environment is restraining the market. The market is also challenged by the availability of alternate technologies and the lack of awareness regarding CRISPR. But, the advancements in the gene-based therapy application and the increased demand for CRISPR will create market opportunities.

The global market report covers the countries from North America, Europe, Asia-Pacific, Latin America and the Middle East and Africa.

Asia-Pacific is likely to be the fastest-growing for the CRISPR market in the world. With the rapidly advancing technological developments and the wide range of applications of CRISPR technology in countries like India and China, regional growth is expected in the next few years. China has already started various gene-editing research work focusing on the CRISPR technology market.

The major companies in the CRISPR market are Horizon Discovery Ltd, Integrated DNA Technologies Inc, Caribou Biosciences Inc, Precision Biosciences, Lonza, Addgene, Origene Technologies Inc, Genedata AG, Intellia Therapeutics Inc, Cellectis, Applied StemCell, Transposagen Bio (Hera BioLabs), GeneCopoeia Inc, Sigma-Aldrich (Merck KGaA), DiaCarta, Editas Medicine, New England Biolabs, Sangamo Therapeutics, GenScript, Thermo Fisher Scientific Inc and CRISPR Therapeutics.

Applied StemCell is a company that aims at stem cell and gene-editing in the field of biotechnology and the biomedical sector. It offers its services in different fields for drug discovery, basic research study, bioproduction and bioprocessing. The company is working on various projects that will combine TARGATT and CRISPR/Cas9 technology. The company is headquartered in California, the US, and has a global presence with business operations in various countries, including Australia, Germany, Belgium, Canada, Denmark, Hong Kong, India, Japan, Malaysia, Thailand and Turkey.

Key Topics Covered:

1. Global CRISPR Market - Summary

2. Industry Outlook2.1. Market Definition2.2. Porter's Five Forces Model2.2.1. Threat of New Entrants2.2.2. Threat of Substitute Products2.2.3. Bargaining Power of Buyers2.2.4. Bargaining Power of Suppliers2.2.5. Competitive Rivalry2.3. Regulatory Outlook2.4. Value Chain Outlook2.5. Supply Chain Outlook2.6. Timeline of Global CRISPR Market2.7. Parent Market Outlook2.8. Key Insight2.9. Market Attractiveness Index2.10. Market Drivers2.10.1. Growing Lifestyle-Oriented Diseases2.10.2. Surging Prevalence of Genetic Diseases2.10.3. Increasing Application of Drugs2.10.4. Rising Aging Population2.10.5. Incidence of Genetic Ailments2.11. Market Restraints2.11.1. Ethical and Social Issues Associated With CRISPR Technology2.11.2. Changing Regulatory Environment2.12. Market Opportunities2.12.1. Increased Demand for CRISPR 2.12.2. Advancements in the Applications of Gene-Based Therapy2.13. Market Challenges2.13.1. Alternative Technologies2.13.2. Lack of Awareness Regarding the Technology

3. CRISPR Market Outlook - By Product3.1. Plasmids3.2. Vectors3.3. Proteins3.3.1. Cas 93.3.2. Cpf13.3.3. Other Proteins3.4. Design Tools3.5. Grna3.6. Control Kits3.7. Library3.8. Other Products

4. CRISPR Market Outlook - By Application4.1. Genome Editing/Genetic Engineering4.1.1. Genetically Modified Organisms4.1.2. Agricultural Biotechnology4.1.3. Other Genome Editing/Genetic Engineering4.2. Grna Database/Gene Library4.3. CRISPR Plasmid4.4. Human Stem Cells4.5. Cell Line Engineering

5. CRISPR Market Outlook - By End-User5.1. Therapeutics and Drug Discovery5.2. Biological Research5.3. Agricultural Biotech5.4. Industrial Biotech

6. CRISPR Market - Regional Outlook6.1. North America6.1.1. Market By Product6.1.2. Market By Application6.1.3. Market By End-User6.1.4. Country Outlook6.1.4.1. the United States6.1.4.2. Canada6.2. Europe6.2.1. Market By Product6.2.2. Market By Application6.2.3. Market By End-User6.2.4. Country Outlook6.2.4.1. the United Kingdom6.2.4.2. France6.2.4.3. Germany6.2.4.4. Spain6.2.4.5. Italy6.2.4.6. Russia6.2.4.7. Rest of Europe6.3. Asia-Pacific6.3.1. Market By Product6.3.2. Market By Application6.3.3. Market By End-User6.3.4. Country Outlook6.3.4.1. India6.3.4.2. China6.3.4.3. Japan6.3.4.4. South Korea6.3.4.5. Australia & New Zealand6.3.4.6. Asean Countries6.3.4.7. Rest of Asia-Pacific6.4. Latin America6.4.1. Market By Product6.4.2. Market By Application6.4.3. Market By End-User6.4.4. Country Outlook6.4.4.1. Brazil6.4.4.2. Mexico6.4.4.3. Rest of Latin America6.5. Middle East and Africa6.5.1. Market By Product6.5.2. Market By Application6.5.3. Market By End-User6.5.4. Country Outlook6.5.4.1. Saudi Arabia6.5.4.2. Turkey6.5.4.3. United Arab Emirates6.5.4.4. South Africa6.5.4.5. Rest of Middle East & Africa

7. Company Profile7.1. Addgene7.2. Applied Stemcell 7.3. Caribou Biosciences Inc7.4. Cellectis7.5. CRISPR Therapeutics 7.6. Diacarta 7.7. Editas Medicine7.8. Genecopoeia Inc7.9. Genedata Ag7.10. Genscript7.11. Horizon Discovery Ltd7.12. Integrated Dna Technologies Inc7.13. Intellia Therapeutics Inc7.14. Lonza 7.15. New England Biolabs 7.16. Origene Technologies Inc7.17. Precision Biosciences7.18. Sangamo Therapeutics7.19. Sigma-Aldrich (Merck Kgaa)7.20. Thermo Fisher Scientific Inc7.21. Transposagen Bio (Hera Biolabs)

8. Research Methodology & Scope8.1. Research Scope & Deliverables8.1.1. Objectives of Study8.1.2. Scope of Study8.2. Sources of Data8.2.1. Primary Data Sources8.2.2. Secondary Data Sources8.3. Research Methodology8.3.1. Evaluation of Proposed Market8.3.2. Identification of Data Sources8.3.3. Assessment of Market Determinants8.3.4. Data Collection8.3.5. Data Validation & Analysis

For more information about this report visit https://www.researchandmarkets.com/r/u9j8i0

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Read the rest here:
Insights on the CRISPR Global Industry to 2028 - Featuring Applied Stemcell, Caribou Biosciences & Cellectis Among Others - GlobeNewswire

This entry was posted on July 1, 2020 at 3:44 am and is filed under Stem Cell Russia. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed. |